Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Tzu Tai

Showing results (161-170 of 211) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivoHiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine WarheadsKrista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
Leukemia|May 31, 2019
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signalingMatthew Ho, Tianzeng Chen, Jiye Liu, et al.
Nature Communications|February 14, 2024
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myelomaJiye Liu, Lijie Xing, Jiang Li, et al.
Cell Reports|July 21, 2015
CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional ActivationAldo M Roccaro, Yuji Mishima, Antonio Sacco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.
Blood|December 18, 2015
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsMichele Cea, Antonia Cagnetta, Sophia Adamia, et al.
Blood|September 20, 2014
Differential and limited expression of mutant alleles in multiple myelomaNaim U Rashid, Adam S Sperling, Niccolo Bolli, et al.
Blood|November 5, 2020
Progression signature underlies clonal evolution and dissemination of multiple myelomaYu Jia Shen, Yuji Mishima, Jiantao Shi, et al.
Blood Advances|October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agentsYuting Yan, Xuehan Mao, Jiahui Liu, et al.
Pageof 22

Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivoHiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine WarheadsKrista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
Leukemia|May 31, 2019
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signalingMatthew Ho, Tianzeng Chen, Jiye Liu, et al.
Nature Communications|February 14, 2024
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myelomaJiye Liu, Lijie Xing, Jiang Li, et al.
Cell Reports|July 21, 2015
CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional ActivationAldo M Roccaro, Yuji Mishima, Antonio Sacco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.
Blood|December 18, 2015
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsMichele Cea, Antonia Cagnetta, Sophia Adamia, et al.
Blood|September 20, 2014
Differential and limited expression of mutant alleles in multiple myelomaNaim U Rashid, Adam S Sperling, Niccolo Bolli, et al.
Blood|November 5, 2020
Progression signature underlies clonal evolution and dissemination of multiple myelomaYu Jia Shen, Yuji Mishima, Jiantao Shi, et al.
Blood Advances|October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agentsYuting Yan, Xuehan Mao, Jiahui Liu, et al.
Pageof 22